logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Lancet Infectious Diseases cover

Lancet Infectious Diseases

IF31
Papers7938
Citations39996
Journal Papers 9576
Publication Date
delete
Pertussis: taking aim at the nose in schoolchildren
deleteLancet Infectious Diseases
IF31
delete2026-10-01
delete0
PREAI
deleteKonstantinos Karampatsas; Eve Nakabembe
deleteShare
deleteSave
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, evaluated with and without tetanus-reduced diphtheria-acellular pertussis vaccine in healthy children aged 6–17 years: a randomised, active-controlled and placebo-controlled, phase 2b trial
deleteLancet Infectious Diseases
IF31
delete2026-10-01
delete0
deleteOAAI
deleteSaul N Faust; Javier Céspedes; Lydiana Avila; Gabriela Ivankovich-Escoto; Helen S Marshall; Peter Richmond; Terry Nolan; Jolanta Bernatoniene; Srini Bandi; Anil Shenoy; Svetlana Rayner; Lisa Weissfeld; Wei Lang; Vivek Samal; Peter Goldstein; Keith Rubin; Camille Locht; Stephanie Noviello
deleteShare
deleteSave
Counteracting the rise of antimicrobial resistance in Shigella
deleteLancet Infectious Diseases
IF31
delete2026-09-23
delete0
PREAI
deletenull The Lancet Infectious Diseases
deleteShare
deleteSave
Bruce Ribner
deleteLancet Infectious Diseases
IF31
delete2026-09-23
delete0
PREAI
deleteUdani Samarasekera
deleteShare
deleteSave
Pragmatic tuberculosis trials must measure what determines implementation
deleteLancet Infectious Diseases
IF31
delete2026-09-16
delete0
PREAI
deleteSayoki Mfinanga; Eleni Aklillu; Alimuddin Zumla
deleteShare
deleteSave
Recalibrating quantitative PCR cycle-thresholds could improve mpox diagnostic accuracy in high-transmission settings
deleteLancet Infectious Diseases
IF31
delete2026-09-15
delete0
PREAI
deleteJean de Dieu Harelimana; Christian Happi
deleteShare
deleteSave
Immunogenicity and safety of an MF59-adjuvanted cell-derived higher-dose quadrivalent influenza vaccine (aQIVc) in adults aged 50 years or older: a phase 3 randomised controlled trial
deleteLancet Infectious Diseases
IF31
delete2026-09-10
delete0
PREAI
deleteBrandon J Essink; Wim Vermeulen; Coralie Andrade; Marta Mazur; Richard de Rooij; Esther Heijnen; Daniela Casula; Ruoyu Xing; Maria Piedrahita Tovar; Vanessa Garner; Frank R Albano
deleteShare
deleteSave
Developing a better flu vaccine
deleteLancet Infectious Diseases
IF31
delete2026-09-10
delete0
PREAI
deleteRobert L Atmar; Hana M El Sahly
deleteShare
deleteSave
South Sudan's first 100 days of Bundibugyo Ebola readiness
deleteLancet Infectious Diseases
IF31
delete2026-09-08
delete0
PREAI
deleteDick Chamla; Marie Roseline Darnycka Belizaire; Arisekola Jinadu; Aggrey Bategereza; Isaias Fernandes; Stella Chunggong; Mohamed Janabi
deleteShare
deleteSave
Is a tiered classification framework needed for sexually transmitted infections?
deleteLancet Infectious Diseases
IF31
delete2026-09-08
delete0
PREAI
deleteIsmaël Maatouk; David A Lewis; Magnus Unemo
deleteShare
deleteSave
deleteLancet Infectious Diseases
IF31
delete2026-09-07
delete0
PREAI
deleteKenneth Chan; Caitlin Greenland-Bews; Daniel P Carter; Matthew Harvey; Cristina Leggio; Abdul Karim Sesay; Joseph Akoi Bore; Thomas Edwards; David J Allen; Sonal Shah
deleteShare
deleteSave
Cross-reactive Bundibugyo antibody responses in Guinean survivors of Ebola virus and recipients of rVSVΔG-ZEBOV-GP (Ervebo) in an outbreak setting
deleteLancet Infectious Diseases
IF31
delete2026-09-04
delete0
PREAI
deleteGrace Hood; Joseph Akoi Bore; Dung Nguyen; Weston Struwe; Miles Carroll
deleteShare
deleteSave
Fighting cholera in the nineteenth century
deleteLancet Infectious Diseases
IF31
delete2026-09-03
delete0
PREAI
deleteManjulika Das
deleteShare
deleteSave
The threat of the superbugs
deleteLancet Infectious Diseases
IF31
delete2026-09-03
delete0
PREAI
deletePeter Ranscombe
deleteShare
deleteSave
Sepsis, endemic and emerging infectious diseases: converging concepts and clinical implications
deleteLancet Infectious Diseases
IF31
delete2026-09-02
delete0
PREAI
deleteReinaldo Salomão; Giuseppe G F Leite; Matias C Salomão; Felipe Dal-Pizzol; Tom van der Poll; Mervyn Singer
deleteShare
deleteSave
Ring and community vaccination for Bundibugyo virus outbreak response: a stochastic network modelling study
deleteLancet Infectious Diseases
IF31
delete2026-09-02
delete0
PREAI
deleteJason R Andrews; Placide K Mbala; Patrick K Mukadi; Jason Kindrachuk; Nicole A Hoff; Anne W Rimoin; Isaac I Bogoch
deleteShare
deleteSave
deleteLancet Infectious Diseases
IF31
delete2026-08-31
delete0
deleteOAAI
deleteLindsey R Baden; Nirav S Shah; Sean T H Liu; Jonathan Cohen; James Moy; Andre Kumar; Grace A McComsey; Peter Chen; Michelle Floris-Moore; Nora G Singer; Inti Fernandez; Alex J Slandzicki; Zanthia Wiley; Alexandra Kadl; David A Kaminsky; Harvey Hsu; Tiffany A Walker; Aluko A Hope; Luis Ostrosky-Zeichner; Jason D Goldman
deleteShare
deleteSave
Curbing neonatal group B streptococcus disease burden
deleteLancet Infectious Diseases
IF31
delete2026-08-25
delete0
PREAI
deleteStephen K Obaro; Nubwa Medugu
deleteShare
deleteSave
Severe health-care-associated infections and antimicrobial resistance in an Asian Surveillance Network (ACORN-HAI): a multicentre, prospective cohort study
deleteLancet Infectious Diseases
IF31
delete2026-08-22
delete0
deleteOAAI
deleteYin Mo; Xinxin Hao; Ying Ding; Yang Cao; Yiying Cai; Suwatthiya Kitsaran; Hock Hin Chua; Sotharith Bory; Sasheela Sri La Sri Ponnampalavanar; Siriluck Anunnatsiri; Mohd Zulfakar Mazlan; Azizullah Khan Dhiloo; Rongpong Plongla; Andrea Lay-Hoon Kwa; Syed Faisal Mahmood; Arthur Dessi Roman; Louise Thwaites; Phan Vinh Tho; Sheng Wu; Darunee Chotiprasitsakul
deleteShare
deleteSave
From estimates to evidence: measuring the true burden of AMR
deleteLancet Infectious Diseases
IF31
delete2026-08-22
delete0
PREAI
deleteAmy J Mathers; Jose M Munita
deleteShare
deleteSave